3-138950544-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001040061.3(FOXL2NB):c.500G>T(p.Ser167Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,192 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001040061.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXL2NB | NM_001040061.3 | c.500G>T | p.Ser167Ile | missense_variant | 3/3 | ENST00000383165.4 | NP_001035150.1 | |
FOXL2NB | XM_005247443.4 | c.431G>T | p.Ser144Ile | missense_variant | 4/4 | XP_005247500.1 | ||
FOXL2NB | XM_024453517.2 | c.*301G>T | 3_prime_UTR_variant | 2/2 | XP_024309285.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXL2NB | ENST00000383165.4 | c.500G>T | p.Ser167Ile | missense_variant | 3/3 | 2 | NM_001040061.3 | ENSP00000372651 | P1 | |
FOXL2NB | ENST00000498709.1 | n.1429G>T | non_coding_transcript_exon_variant | 2/2 | 2 | |||||
FOXL2NB | ENST00000470680.5 | c.*382G>T | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 3 | ENSP00000418272 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152204Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461870Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727232
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152322Hom.: 1 Cov.: 32 AF XY: 0.0000537 AC XY: 4AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2021 | The c.500G>T (p.S167I) alteration is located in exon 3 (coding exon 3) of the FOXL2NB gene. This alteration results from a G to T substitution at nucleotide position 500, causing the serine (S) at amino acid position 167 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at